Kidney cancer: PBRM1 loss promotes tumour response to immunotherapy – Nature.com
Nature.com |
Kidney cancer: PBRM1 loss promotes tumour response to immunotherapy
Nature.com “Taken together, these findings suggest that chromatin dysregulation may be a new avenue towards understanding why patients with ccRCC (and other types of cancer) respond to ICB,” says Van Allen. “This discovery warrants further experimental and … |
